📰 Bert Coessens News
Bert Coessens News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bert Coessens. Real-time updates on events, politics, business and more.
October 25, 2023
MyNEO Therapeutics to focus on building proprietary product pipeline based on a novel class of shared therapeutic cancer targets derived from the dark genome named “camyotopes” Lead product CAMYO-01 incorporates a pool of colorectal cancer-specific camyotopes formulated into an mRNA-based vaccineCAMYO-01 is advancing towards clinical development for the treatment of colorectal cancer GHENT, Belgium – October 25th 2023. myNEO, a biotech company focused on exploiting “d...
October 25, 2023
myNEO Therapeutics to focus on building proprietary product pipeline based on a novel class of shared therapeutic cancer targets derived from the dark...
May 25, 2022
Issuer: CureVac / Key word(s): Alliance25.05.2022 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development CureVac is broadening its foundation in oncology, leveraging recent progress with it...
May 25, 2022
Issuer: CureVac / Key word(s): Alliance CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine ...
May 25, 2022
CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backboneThe partnership combines CureVac's mRNA technology with myNEO's platform for the discovery
May 25, 2022
DGAP-News: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development